Astra Industrial Group Company (1212.SR)
- Previous Close
149.20 - Open
149.20 - Bid 149.40 x --
- Ask 149.60 x --
- Day's Range
149.00 - 150.20 - 52 Week Range
125.60 - 207.00 - Volume
20,578 - Avg. Volume
140,238 - Market Cap (intraday)
11.968B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
21.62 - EPS (TTM)
6.92 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield 3.00 (2.00%)
- Ex-Dividend Date Apr 21, 2025
- 1y Target Est
184.33
Astra Industrial Group Company, through its subsidiaries, engages in the pharmaceuticals, specialty chemicals, power, steel, and mining businesses worldwide. The company develops, manufactures, markets, and distributes branded generic and under-licensed pharmaceuticals products in various therapeutic areas, including CNS, cardiovascular, anti-infective, respiratory, and muscular skeletal system; and produces masterbatches, dust-free additives, and custom-made thermoplastic compounds, and liquid and paste colorants for polymer manufacturing and polymer converting, and plastic processing industries. It also manufactures, imports, and distributes a range of agrochemicals, fertilizers, public health and veterinary pesticides, seeds, and other agricultural inputs; and produces pre-engineered steel buildings and steel structures, as well as steel billets and rebars. In addition, the company explores for ores and minerals. Further, it builds, operates, manages, and invests in industrial plants. Additionally, it is involved in the metal based construction of buildings and building frames. The company was incorporated in 1988 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
www.aig.saRecent News: 1212.SR
View MorePerformance Overview: 1212.SR
Trailing total returns as of 5/11/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1212.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1212.SR
View MoreValuation Measures
Market Cap
12.00B
Enterprise Value
11.67B
Trailing P/E
21.71
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.92
Price/Book (mrq)
4.75
Enterprise Value/Revenue
3.81
Enterprise Value/EBITDA
14.33
Financial Highlights
Profitability and Income Statement
Profit Margin
20.03%
Return on Assets (ttm)
9.38%
Return on Equity (ttm)
23.06%
Revenue (ttm)
3.05B
Net Income Avi to Common (ttm)
563.26M
Diluted EPS (ttm)
6.92
Balance Sheet and Cash Flow
Total Cash (mrq)
1.09B
Total Debt/Equity (mrq)
22.48%
Levered Free Cash Flow (ttm)
409.26M